Trial Profile
Effects of Calcitriol (1 alpha, 25-[OH]2 Vitamin D3) on Renin Expression in Hypertensive Patients Without Vitamin D Deficiency
Status:
Discontinued
Phase of Trial:
Phase 0
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Calcitriol (Primary)
- Indications Hypertension
- Focus Pharmacodynamics
- 25 May 2016 Status changed from completed to discontinued due to lack of quality data.
- 04 Aug 2011 New trial record